Preview

Антибиотики и Химиотерапия

Расширенный поиск

Биологически активные нерибосомальные пептиды. II. Нерибосомальные пептиды различного биологического действия

Аннотация

Вторая часть обзора, посвященного изучению нерибосомальных пептидов.

Об авторах

Т. И. Орлова
Московский государственный университет им. М.В. Ломоносова
Россия


В. Г. Булгакова
Московский государственный университет им. М.В. Ломоносова
Россия


А. Н. Полин
Московский государственный университет им. М.В. Ломоносова
Россия


Список литературы

1. Mikami Y., Takahashi K., Yazawa K. et al. Structural studies on minor components of saframycin group antibiotics: saframycins F, G and H. J Antibiot 1988; 41: 6: 734-740.

2. Kishi K., Yazawa K., Takahashi K. et al. Structure-activity relationships of saframycins. Ibid 1984; 37: 8: 847-852.

3. Lown J.W., Joshua A.V., Lee J.S. Molecular mechanisms of binding and single-strand scission of deoxyribonucleic acid by the antitumor antibiotics saframycins A and C. Biochemistry 1982; 21: 3: 419-428.

4. Ishiguro K., Takahashi K., Yazawa K. et al. Binding of saframycin A, a heterocyclic quinine anti-tumor antibiotic to DNA as revealed by the use of the antibiotic labeled with [14C]tyrosine or [14C]cyanide. J Biol Chem 1981; 256: 5: 2162-2167.

5. Ueda H., Nakajima H., Hori Y. et al. FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No968.I. Taxonomy, fermentation, isolation, physico-chemical and biological properties, and antitumor activity. J Antibiot 1994; 47: 301-310.

6. Xiao J.J., Byrd J., Marcucci G. et al. Identification of thiols and glutathione conjugates of depsipeptide FK228 (FR901228), a novel histone protein deacetylase inhibitor, in the blood. Rapid Commun. Mass Spectrom 2003; 17: 757-766.

7. Hara M., Takahashi I., Yoshida M. et al. DC 107, a novel antitumor antibiotic produced by a Streptomycessp. J Antibiot 1989; 42: 2: 333-336.

8. Cheng Y.-Q., Tang G.-L., Shen B. Identification and localization of the gene claster encoding biosynthesis of the antitumor macrolactam leinamycin in Streptomyces atroolivaceus S-140. J Bacteriol 2002; 184: 24: 7013-7024.

9. Hara M., Saitoh Y., Nakano H. DNA strand scission by the novel antitumor antibiotic leinamycin. Biochemistry 1990; 29: 24: 5676-5681.

10. Maehr H., Liu C.-M., Palleroni N.J., Smallheer J. et al. Microbial products. VIII. Azinothricin, a novel hexadepsipeptide antibiotic. J Antibiot 1986; 39: 1: 17-25.

11. Maskey R.P., Fotso S., Sevvana M. et al. Kettapeptin: isolation, elucidation and activity of a new hexadepsipeptide antibiotic from a terrestrial Streptomyces sp. J Antibiot 2007; 59: 5: 309-314.

12. Uchihata Y., Ando N., Ikeda Y. et al. Isolation of a novel cyclic hexadepsipeptide pipalamycin from Streptomyces as an apoptosis-inducing agent. J Antibiot 2002; 55: 1: 1-5.

13. Sugawara K., Toda S., Moriyama T. et al. Verucopeptin, a new antitumor antibiotic active against B16 melanoma. II. Structure determination. J Antibiot 1993; 46: 6: 928-935.

14. Sakai Y., Yoshida T., Tsujita T. et al. GE3, a novel hexadepsipeptide antitumor antibiotic, produced by Streptomyces sp. J Antibiot 1997: 50: 8: 659-664.

15. Nakagawa M., Hayakawa Y., Furihata K., Seto H. Structural studies on new depsipeptide antibiotics, variapeptin and citropeptin. J Antibiot 1990; 43: 5: 477-484.

16. Agatsuma T., Sakai Y., Mizukami T., Saitoh Y. GE3, a novel hexadepsipeptide antitumor antibiotic, produced by Streptomyces sp. J Antibiot 1997: 50: 8: 704-709.

17. Xiang W.-S., Wang J.-D., Wang X.-J., Zhang J. Bingchamides A and B, two novel cyclic pentapeptides from the Streptomyces bingchenggensis: fermentation, isolation, structure elucidation and biological properties. J Antibiot 2009; 62: 9: 501-505.

18. Dalsgaard P.W., Larsen T.O., Christophersen C. Bioactive cyclic peptides from the psychrotolerant fungus Penicillium algidum. J Antibiot 2005; 58: 2: 141-144.

19. Matsuo Y., Kanoh K., Yamori T. et al. Urukthapelstatin A, a novel cytotoxic substance from marine-derived Mechercharimyces asporophorigenes YM11-542. 1. Fermentation, isolation and biological activities. J Antibiot 2007; 60: 4: 251-255.

20. Matsuo Y., Kanoh K., ImagawaH. et al. Urukthapelstatin A, a novel cytotoxic substance from marine-derived Mechercharimyces asporophorigenes YM11-542. 11. Physico-chemical properties and structural elucidation. J Antibiot 2007; 60: 4: 256-260.

21. Tan L.T., Cheng X.C., Jensen P.R., Fenical W. Scytalidamides A and B, new cytotoxic cyclic heptapeptides from a marine fungus of the genus Scytalidium. J Org Chem 2003; 68: 23: 8767-8773.

22. Shiono Y., Tsuchinari M., Shimanuki K. et al. Fusaristatins A and B, two new cyclic lipopeptides from an endophytic Fusarium sp. J Antibiot 2007; 60: 5: 309-316.

23. McBrien K.D., Berry R.L., Lovve S.E. Rakicidins, a new cytotoxic lipopeptides from Micromonospora sp. Fermentation, isolation and characterization. J Antibiot 1995; 48: 12: 1445-1452.

24. Kracht M., Rokos H., Ozel M. et al. Antiviral and hemolytic activities of surfactin isoforms and their methyl ester derivatives. J Antibiot 1999; 52: 7: 613-619.

25. Shin C.-G., An D.-G., Song H.-H., Lee C. Beauvericin and enniatins H, I and MK1688 are new potent inhibitors of human immunodeficiency virus type-1 integrase. Beauvericin and enniatins H, I and MK1688 are inhibitors of HIV-1 integrase. J Antibiot 2009; 62: 12: 687-690.

26. Sasse F., Steinmetz H., Schupp T. et al. Argyrins, immunosuppressive cyclic peptides from myxobacteria.I. Production, isolation, physicochemical and biological properties. J Antibiot 2002; 55: 6: 543-551.

27. Vollbrecht L., Steinmetz H., Hofle G. et al. Argyrins, immunosuppressive cyclic peptides from myxobacteria. II. Structure elucidation and stereochemistry. J Antibiot 2002; 55: 8: 715-721.

28. Takahashi T., Ohno O., Ikeda Y. et al. Inhibition of lipopolysaccharide activity by a bacterial cyclic lipopeptide surfactin. J Antibiot 2006; 59: 1: 35-43.

29. Matsuzaki K., Ikeda H., Ogino T. et al. Chloropeptines I and II, novel inhibitors against gp120-CD4 binding from Streptomyces sp. J Antibiot 1994; 47: 10: 1173-1174.

30. Kaneko I., Kamoshida K., Takahashi S. Complestatin, a potent anticomplement substance produced by Streptomyces lavendulae.I. Fermentation, isolation and biological characterization. J Antibiot 1989; 42: 2: 236-241.

31. Namatame I., Tomoda H., Si S. et al. Beauveriolides, specific inhibitors of lipid droplet formation in mouse macrophages, produced by Beauveria sp. FQ-6979. J Antibiot 1999; 52: 1: 1-6.

32. Namatame I., Tomoda H., Tabata N. et al. Structure elucidation of fungal beauveriolide III, a novel inhibitor of lipid formation in mouse macrophages. J Antibiot 1999; 52: 1: 7-12.

33. Adachi K., Kanoh K., Wisespongp P. et al. Clonostachysins A and B, new antidinoflagellate cyclic peptides from a marine-derived fungus. J Antibiot 2005; 58: 2: 145-150.

34. Fredenhagen A., Molleyres L.-P., Bolendorf B., Laue G. Structure determination of neoefrapeptins A to N: peptides with insecticidal activity produced by the fungus Geotrichum candidum. J Antibiot 2006; 59: 5: 267-280.

35. Grangemard I., Bonmatin J.-M., Bernillon J. et al. Lichenysins G, a novel family of lipopeptide biosurfactants from Bacillus licheniformis IM1307: production, isolation and structural evaluation by NMR and mass spectrometry. J Antibiot 1999; 52: 4: 363-373.

36. Lipmann F. Attempts to map a progress evolution of peptide biosynthesis. Science 1971; 173: 4000: 875-884.

37. Бибикова М.В., Пушевская Т.О., Катлинский А.В. Гифомицеты - продуценты циклодепсипептидных соединений. Антибиотики и химиотер. 2010; 55: 2-4: 35-44.

38. Соболевская М.П., Кузнецова Т.А. Биоактивные соединения морских актиномицетов. Биоорган химия 2010; 36: 5: 607-621.


Рецензия

Для цитирования:


Орлова Т.И., Булгакова В.Г., Полин А.Н. Биологически активные нерибосомальные пептиды. II. Нерибосомальные пептиды различного биологического действия. Антибиотики и Химиотерапия. 2011;56(11-12):30-33.

For citation:


Orlova T.I., Bulgakova V.G., Polin A.N. Biologically Active Nonribosomal Peptides. II. Nonribosomal Peptides of Various Biological Action. Antibiot Khimioter = Antibiotics and Chemotherapy. 2011;56(11-12):30-33. (In Russ.)

Просмотров: 267


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 0235-2990 (Print)